AZTA as reported
Azenta, Inc. reported $596M of revenue over the trailing twelve months, +1.8% on the year before. 11 reported series are charted on this page, each one as filed.
$596M
Revenue, trailing twelve months · to Q2 2026 · +1.8% against the twelve months before
- Net Income
- −$173M
Net Income · +141% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $30M
Free Cash Flow · −22% year on year · trailing twelve months to Q2 2026
- Op Margin
- −30%
Op Margin · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $596M | +1.8% | Q2 2026 |
| Net Income | −$173M | +141% | Q2 2026 |
| EPS | −$3.77 | +143% | Q2 2026 |
| Gross Margin | 44% | n/a | Q2 2026 |
| Op Margin | −30% | n/a | Q2 2026 |
| Net Margin | −31% | n/a | Q2 2026 |
| ROE | −6.2% | n/a | Q2 2026 |
| ROA | −5.1% | n/a | Q2 2026 |
| ROIC | −1.7% | n/a | Q1 2022 · 17 quarters behind |
| Free Cash Flow | $30M | −22% | Q2 2026 |
| P/E | 63.4 | n/a | Q1 2022 · 17 quarters behind |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Azenta, Inc. (AZTA) - Revenue & ProfitRevenue & ProfitAzenta, Inc. (AZTA)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Instruments & Supplies
Ranks #24 of 27 by Smart Score